- Correspondence to Dr Sudha Visvanathan, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877, USA;
- Received November 8, 2018
- Revised February 20, 2019
- Accepted February 24, 2019
- First published March 22, 2019.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.